Cargando…

The impact of export regulations on recombinant viral vaccine development for emerging infectious diseases

Detalles Bibliográficos
Autores principales: Wolf, Jayanthi, Hansen, Ryan, Hassis, Kimberly, Lapps, William, Warmuth, Emese
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7535798/
https://www.ncbi.nlm.nih.gov/pubmed/33032845
http://dx.doi.org/10.1016/j.vaccine.2020.09.057
_version_ 1783590460491563008
author Wolf, Jayanthi
Hansen, Ryan
Hassis, Kimberly
Lapps, William
Warmuth, Emese
author_facet Wolf, Jayanthi
Hansen, Ryan
Hassis, Kimberly
Lapps, William
Warmuth, Emese
author_sort Wolf, Jayanthi
collection PubMed
description
format Online
Article
Text
id pubmed-7535798
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-75357982020-10-06 The impact of export regulations on recombinant viral vaccine development for emerging infectious diseases Wolf, Jayanthi Hansen, Ryan Hassis, Kimberly Lapps, William Warmuth, Emese Vaccine Commentary Elsevier Ltd. 2020-10-27 2020-10-05 /pmc/articles/PMC7535798/ /pubmed/33032845 http://dx.doi.org/10.1016/j.vaccine.2020.09.057 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Commentary
Wolf, Jayanthi
Hansen, Ryan
Hassis, Kimberly
Lapps, William
Warmuth, Emese
The impact of export regulations on recombinant viral vaccine development for emerging infectious diseases
title The impact of export regulations on recombinant viral vaccine development for emerging infectious diseases
title_full The impact of export regulations on recombinant viral vaccine development for emerging infectious diseases
title_fullStr The impact of export regulations on recombinant viral vaccine development for emerging infectious diseases
title_full_unstemmed The impact of export regulations on recombinant viral vaccine development for emerging infectious diseases
title_short The impact of export regulations on recombinant viral vaccine development for emerging infectious diseases
title_sort impact of export regulations on recombinant viral vaccine development for emerging infectious diseases
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7535798/
https://www.ncbi.nlm.nih.gov/pubmed/33032845
http://dx.doi.org/10.1016/j.vaccine.2020.09.057
work_keys_str_mv AT wolfjayanthi theimpactofexportregulationsonrecombinantviralvaccinedevelopmentforemerginginfectiousdiseases
AT hansenryan theimpactofexportregulationsonrecombinantviralvaccinedevelopmentforemerginginfectiousdiseases
AT hassiskimberly theimpactofexportregulationsonrecombinantviralvaccinedevelopmentforemerginginfectiousdiseases
AT lappswilliam theimpactofexportregulationsonrecombinantviralvaccinedevelopmentforemerginginfectiousdiseases
AT warmuthemese theimpactofexportregulationsonrecombinantviralvaccinedevelopmentforemerginginfectiousdiseases
AT wolfjayanthi impactofexportregulationsonrecombinantviralvaccinedevelopmentforemerginginfectiousdiseases
AT hansenryan impactofexportregulationsonrecombinantviralvaccinedevelopmentforemerginginfectiousdiseases
AT hassiskimberly impactofexportregulationsonrecombinantviralvaccinedevelopmentforemerginginfectiousdiseases
AT lappswilliam impactofexportregulationsonrecombinantviralvaccinedevelopmentforemerginginfectiousdiseases
AT warmuthemese impactofexportregulationsonrecombinantviralvaccinedevelopmentforemerginginfectiousdiseases